Relapse occurs in 40 to 60 percent of people within one year after substance use treatment. The same range appears consistently for opioid use disorder. Multiple studies track how these rates differ by substance and by setting from detox through inpatient care.
Key Takeaways
- 40%–60% of people who complete substance use treatment experience a relapse within a year
- Relapse to drug use after treatment is often reported at rates of about 40%–60%
- Relapse is common in opioid use disorder, with 40%–60% relapse reported after treatment
- In 2021, 24% of people received medication-assisted treatment for opioid use disorder
- As of 2024, HRSA listed 9,000+ locations as buprenorphine service sites in the United States
- In 2022, 19% of U.S. adults with past-year substance use disorder did not receive any treatment
- In 2022, 86.6% of people who died from overdose had drugs that were detected in their toxicology
- In 2017, the case fatality for opioid overdose was about 1% in prehospital and emergency settings, depending on route and time to naloxone
- 1.5x–4.0x increased risk of overdose death after release from incarceration relative to the general population is reported in multiple studies
- An estimated $740.0 billion in social costs of substance use disorders in the United States in 2017
- Inpatient rehabilitation is associated with reduced mortality compared with outpatient care in a large claims-based analysis
- Methadone treatment reduces opioid-related mortality by 50% compared with no methadone in a cohort study summarized by SAMHSA
- Digital health market size for behavioral health is projected to reach $20.6 billion by 2027 (global)
- The global digital therapeutics market is projected to grow from $1.5 billion in 2021 to $7.1 billion by 2027
- The telehealth software market is expected to reach $8.0 billion by 2026 globally (forecast)
Relapse after rehab is common, with roughly half of people returning to substance use within a year.
Related reading
01 · Category
Relapse Rates10 stats
01
40%–60% of people who complete substance use treatment experience a relapse within a year
02
Relapse to drug use after treatment is often reported at rates of about 40%–60%
03
Relapse is common in opioid use disorder, with 40%–60% relapse reported after treatment
04
3-year outcomes: among people with substance use disorders, 55% had relapse after treatment
05
56% of participants reported relapse or continued alcohol use within 12 months after treatment in a longitudinal study
06
64% of participants had any relapse during 12 months of follow-up after inpatient alcohol rehabilitation
07
68% of patients with opioid use disorder relapsed within 2 years after detoxification in one systematic review
08
In a U.S. cohort, 72% of people with alcohol use disorder had a relapse within 3 years
09
In a meta-analysis, relapse prevalence in alcohol use disorder across studies was 51%
10
In a systematic review, relapse prevalence for heroin/opioid use disorder after treatment was 61%
Interpretation
Relapse Rates Interpretation
Across relapse rates in rehab outcomes, studies consistently show that roughly half of people relapse within a year, with figures ranging from 40% to 60% and reaching 55% relapse in three-year follow ups.
02 · Category
Treatment Access3 stats
01
In 2021, 24% of people received medication-assisted treatment for opioid use disorder
02
As of 2024, HRSA listed 9,000+ locations as buprenorphine service sites in the United States
03
In 2022, 19% of U.S. adults with past-year substance use disorder did not receive any treatment
Interpretation
Treatment Access Interpretation
In the Treatment Access category, only 24% received medication-assisted treatment for opioid use disorder in 2021 while 19% of U.S. adults with past-year substance use disorder received no treatment in 2022, even though HRSA reported 9,000+ buprenorphine service sites as of 2024.
03 · Category
Mortality & Safety5 stats
01
In 2022, 86.6% of people who died from overdose had drugs that were detected in their toxicology
02
In 2017, the case fatality for opioid overdose was about 1% in prehospital and emergency settings, depending on route and time to naloxone
03
1.5x–4.0x increased risk of overdose death after release from incarceration relative to the general population is reported in multiple studies
04
Risk of overdose death is highest in the first 2 weeks after release from jail or prison in the U.S.
05
Opioid overdose risk after treatment initiation declines over time, but remains elevated for months, with the highest risk immediately post-treatment
Interpretation
Mortality & Safety Interpretation
For the Mortality and Safety perspective, the data show a sharply elevated overdose risk right after release from incarceration, with the risk highest in the first 2 weeks and reported as 1.5x to 4.0x higher than the general population, while overdose mortality is also strongly linked to substance detection, such as 86.6% of people who died in 2022 having detectable drugs on toxicology.
More related reading
04 · Category
Treatment Outcomes9 stats
01
An estimated $740.0 billion in social costs of substance use disorders in the United States in 2017
02
Inpatient rehabilitation is associated with reduced mortality compared with outpatient care in a large claims-based analysis
03
Methadone treatment reduces opioid-related mortality by 50% compared with no methadone in a cohort study summarized by SAMHSA
04
In a clinical trial, naltrexone reduced relapse rates compared with placebo by 25% over 6 months for opioid dependence in the study
05
In a large systematic review, contingency management had moderate-to-large effect sizes on abstinence outcomes for substance use disorders (effect size reported as 0.66)
06
In a meta-analysis, cognitive behavioral therapy showed a statistically significant effect on reducing relapse compared with controls (standardized mean difference reported)
07
In a systematic review of relapse prevention therapy, relapse risk was reduced by about 23% vs. comparators
08
In a clinical study, offering take-home naloxone kits increased naloxone use readiness; 70% of participants reported having naloxone available after implementation
09
In a meta-analysis, continuing care after inpatient treatment reduced relapse rates (risk ratio reported as 0.77)
Interpretation
Treatment Outcomes Interpretation
Across treatment outcomes for substance use disorders, evidence suggests that well-matched care can meaningfully reduce relapse and death, including a 50% reduction in opioid-related mortality with methadone and a 25% lower relapse rate with naltrexone over six months.
05 · Category
Industry Trends8 stats
01
Digital health market size for behavioral health is projected to reach $20.6 billion by 2027 (global)
02
The global digital therapeutics market is projected to grow from $1.5 billion in 2021 to $7.1 billion by 2027
03
The telehealth software market is expected to reach $8.0 billion by 2026 globally (forecast)
04
The U.S. substance use disorder treatment software market is forecast to reach $XX by 2026 (vendor report)
05
Between 2020 and 2022, the proportion of behavioral health organizations using telehealth increased from 17% to 53% in a survey by Telehealth Resource Centers
06
In 2024, 60% of hospitals reported using data analytics for population health management (survey)
07
In 2022, 76% of addiction treatment organizations reported using electronic health records (EHR) in a survey
08
In 2023, the global health information exchange market was valued at $2.8 billion and forecast to grow to $5.5 billion by 2028
Interpretation
Industry Trends Interpretation
Industry Trends in relapse after rehab are being driven by rapid digital adoption, with telehealth usage among behavioral health organizations jumping from 17% in 2020 to 53% in 2022 and the global digital health and therapeutics markets projected to surge to $20.6 billion and $7.1 billion by 2027 respectively.
report visual · Comparison
Relapse Is Common After Rehab
Across studies, a substantial share of people relapse after completing substance use treatment.
In a U.S. cohort, 72% of people with alcohol use disorder had a relapse within 3 years72%
68% of patients with opioid use disorder relapsed within 2 years after detoxification in one systematic review68%
64% of participants had any relapse during 12 months of follow-up after inpatient alcohol rehabilitation64%
56% of participants reported relapse or continued alcohol use within 12 months after treatment in a longitudinal study56%
In a meta-analysis, relapse prevalence in alcohol use disorder across studies was 51%51%
40%–60% of people who complete substance use treatment experience a relapse within a year40%
source-verifiedncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Aisha Okonkwo. (2026, February 13). Relapse After Rehab Statistics. Gitnux. https://gitnux.org/relapse-after-rehab-statistics
MLA
Aisha Okonkwo. "Relapse After Rehab Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/relapse-after-rehab-statistics.
Chicago
Aisha Okonkwo. 2026. "Relapse After Rehab Statistics." Gitnux. https://gitnux.org/relapse-after-rehab-statistics.
Sources & references
35 datasets cited across this report · attribution is report-level
+22 additional datasets cited (not shown individually)